Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 13;15(1):8755.
doi: 10.1038/s41598-025-92477-9.

The association between aldosterone and lipid profiles in patients with primary aldosteronism

Affiliations

The association between aldosterone and lipid profiles in patients with primary aldosteronism

Ning-Peng Liang et al. Sci Rep. .

Abstract

Previous studies have yielded inconsistent findings regarding the comparison of lipid profiles in patients with primary aldosteronism (PA) and essential hypertension (EH), and there is a limited understanding of the association between plasma aldosterone concentration (PAC) and lipid profiles across various populations. 270 patients with PA and 598 patients with EH diagnosed at the Second Affiliated Hospital of Nanchang University from January 2020 to June 2021 were consecutively included. After 1:1 propensity score matching by sex, age, and body mass index (BMI), 267 PA and 267 EH patients were ultimately enrolled in the study. The relationship between PAC and lipids was explored. Compared with EH patients, PA patients showed significantly lower levels of total cholesterol (TC) (P = 0.003), low-density lipoprotein cholesterol (LDL-C) (P < 0.001) and non-high-density lipoprotein cholesterol (Non-HDL-C) (P = 0.014). Log TC (P = 0.0256), log triglyceride (TG) (P = 0.0497) and log Non-HDL-C (P = 0.0184) levels were negatively correlated with log PAC in PA patients. Consistently, these lipids yielded similar results with aldosterone/renin ratio (ARR). However, the correlation does not exist in EH patients. The levels of TC, LDL-C and Non-HDL-C were significantly lower in PA than in EH patients. And a significant independent inverse association between log TC, log TG, log Non-HDL-C, and log PAC levels in PA patients. However, the above associations were not always present in clinically matched EH patients.

Keywords: Aldosterone; Dyslipidemia; Essential hypertension; Primary aldosteronism.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Ethical approval: This study was approved by the ethics committee of the Second Affiliated Hospital of Nanchang University and was part of the study of the Nanchang Primary Aldosteronism Study (IIT-O-2021-032). It was registered on chictr.org (ChiCTR2200057297). Signed informed consent was obtained from each patient before participation.

Figures

Fig. 1
Fig. 1
Subgroup analysis of PAC and blood lipid components in PA patients. BMI body mass index, EH essential hypertension, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, PA primary aldosteronism, PAC plasma aldosterone concentration, TC total cholesterol, TG triglycerides. PAC, TG, TC, HDL-C, and LDL-C were log-transformed with base 10. Adjusted for sex, age, BMI, duration of hypertension, diabetes mellitus, smoking history, drinking history, using antihypertensive drugs, Blood potassium, eGFR, fasting blood glucose, glycosylated hemoglobin, standing PRA, 24 h mean SBP, 24 h mean DBP.
Fig. 1
Fig. 1
Subgroup analysis of PAC and blood lipid components in PA patients. BMI body mass index, EH essential hypertension, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, PA primary aldosteronism, PAC plasma aldosterone concentration, TC total cholesterol, TG triglycerides. PAC, TG, TC, HDL-C, and LDL-C were log-transformed with base 10. Adjusted for sex, age, BMI, duration of hypertension, diabetes mellitus, smoking history, drinking history, using antihypertensive drugs, Blood potassium, eGFR, fasting blood glucose, glycosylated hemoglobin, standing PRA, 24 h mean SBP, 24 h mean DBP.

Similar articles

Cited by

References

    1. Catapano, A. L. et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur. Heart J.37, 2999–3058. 10.1093/eurheartj/ehw272 (2016). - PubMed
    1. Turchi, F. et al. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. Nutr. Metab. Cardiovasc. Dis.24, 476–482. 10.1016/j.numecd.2013.09.009 (2014). - PubMed
    1. Milliez, P. et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol.45, 1243–1248. 10.1016/j.jacc.2005.01.015 (2005). - PubMed
    1. Monticone, S. et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol.6, 41–50. 10.1016/S2213-8587(17)30319-4 (2018). - PubMed
    1. Savard, S., Amar, L., Plouin, P. F. & Steichen, O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension62, 331–336. 10.1161/HYPERTENSIONAHA.113.01060 (2013). - PubMed

LinkOut - more resources